Rongfu Wang

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes [published erratum appears in J Exp Med 1995 Mar 1;181(3):1261]

S. Rosenberg, R. Wang, P. Robbins, 1995, The Journal of experimental medicine.

NY-ESO-1 may be a potential target for lung cancer immunotherapy.

D. Schrump, B. Johnson, A. Mixon, 1999, The cancer journal from Scientific American.

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen.

S. Rosenberg, S. Topalian, R. Wang, 1999, Science.

Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33.

A. Sette, S. Rosenberg, R. Wang, 1998, Journal of immunology.

A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames.

S. Rosenberg, S. Topalian, R. Wang, 1998, Journal of immunology.

Identification of the genes encoding cancer antigens: implications for cancer immunotherapy.

S. Rosenberg, R. Wang, P. Robbins, 1996, Advances in cancer research.

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes.

K. Sakaguchi, E. Appella, S. Rosenberg, 1995, Journal of immunology.